Publicaciones (129) Publicaciones de César Alejandro Soutullo Esperón

2024

  1. Development of a Short Version of the ADHD Rating Scale-IV.es (sADHD-RS-IV.es)

    Journal of Attention Disorders, Vol. 28, Núm. 5, pp. 600-607

2021

  1. Resting-State fMRI to Identify the Brain Correlates of Treatment Response to Medications in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Lessons From the CUNMET Study

    Frontiers in Psychiatry, Vol. 12

  2. Systematic Review: Medication Effects on Brain Intrinsic Functional Connectivity in Patients With Attention-Deficit/Hyperactivity Disorder

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 60, Núm. 2, pp. 222-235

2020

  1. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group

    The Lancet Child and Adolescent Health

  2. Isn’t the evidence base for pediatric bipolar disorder already sufficient to inform clinical practice?

    Bipolar Disorders, Vol. 22, Núm. 7, pp. 664-665

2019

  1. Clinical and neuropsychological predictors of methylphenidate response in children and adolescents with adhd: A naturalistic follow-up study in a Spanish sample

    Clinical Practice and Epidemiology in Mental Health, Vol. 15, Núm. 1, pp. 160-171

  2. Normative ADHD-RS-Preschool Data in a Community Sample in Spain

    Journal of Attention Disorders, Vol. 23, Núm. 6, pp. 615-623

  3. Phenomenology and diagnostic stability of paediatric bipolar disorder in a Spanish sample

    Journal of Affective Disorders, Vol. 242, pp. 224-233

  4. Validation of a Spanish-language version of the ADHD Rating Scale IV in a Spanish sample

    Neurologia, Vol. 34, Núm. 9, pp. 563-572

2018

  1. Attention deficit hyperactivity disorder as a risk factor in unintentional poisonings and injuries

    Anales de Pediatria

  2. Attention deficit hyperactivity disorder in preschool age children. Its epidemiological prevalence in Navarra and La Rioja, Spain

    Revista de Neurologia, Vol. 66, pp. S115-S120

  3. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

    CNS Drugs, Vol. 32, Núm. 5, pp. 455-467

  4. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: A descriptive analysis

    BMC Psychiatry, Vol. 18, Núm. 1

  5. Practitioner review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder

    Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 59, Núm. 9, pp. 932-947

  6. Risk of poisoning in children and adolescents with ADHD: a systematic review and meta-analysis

    Scientific Reports, Vol. 8, Núm. 1

  7. Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis

    Neuroscience and Biobehavioral Reviews, Vol. 84, pp. 63-71

  8. Trastorno por déficit de atención e hiperactividad como factor de riesgo en intoxicaciones y lesiones no intencionales

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 88, Núm. 5, pp. 294-295

2017

  1. Convivir con niños y adolescentes con trastorno por déficit de atención e hiperactividad (TDAH)

    Médica Panamericana

  2. Desarrollo psicomotor y dificultades del aprendizaje en preescolares con probable trastorno por déficit de atención e hiperactividad. Estudio epidemiológico en Navarra y La Rioja

    Neurologia, Vol. 32, Núm. 8, pp. 487-493

  3. Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

    CNS Drugs, Vol. 31, Núm. 7, pp. 625-638